These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23561946)

  • 1. Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease -- a randomized study.
    Rios Romenets S; Creti L; Fichten C; Bailes S; Libman E; Pelletier A; Postuma RB
    Parkinsonism Relat Disord; 2013 Jul; 19(7):670-5. PubMed ID: 23561946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study.
    Hajak G; Rodenbeck A; Voderholzer U; Riemann D; Cohrs S; Hohagen F; Berger M; Rüther E
    J Clin Psychiatry; 2001 Jun; 62(6):453-63. PubMed ID: 11465523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.
    Krystal AD; Durrence HH; Scharf M; Jochelson P; Rogowski R; Ludington E; Roth T
    Sleep; 2010 Nov; 33(11):1553-61. PubMed ID: 21102997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between sleep disorders and other non-motor symptoms in Parkinson's disease.
    Kurtis MM; Rodriguez-Blazquez C; Martinez-Martin P;
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1152-5. PubMed ID: 23953775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia.
    Lankford A; Rogowski R; Essink B; Ludington E; Heith Durrence H; Roth T
    Sleep Med; 2012 Feb; 13(2):133-8. PubMed ID: 22197474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose doxepin for the treatment of insomnia: emerging data.
    Goforth HW
    Expert Opin Pharmacother; 2009 Jul; 10(10):1649-55. PubMed ID: 19496739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trial.
    Garland SN; Carlson LE; Stephens AJ; Antle MC; Samuels C; Campbell TS
    J Clin Oncol; 2014 Feb; 32(5):449-57. PubMed ID: 24395850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of Cognitive-Behavioural Therapy (CBT) as related to sleep quality and hyperarousal level in the treatment of primary insomnia.
    Gałuszko-Węgielnik M; Jakuszkowiak-Wojten K; Wiglusz MS; Cubała WJ; Landowski J
    Psychiatr Danub; 2012 Sep; 24 Suppl 1():S51-5. PubMed ID: 22945187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial.
    Cortesi F; Giannotti F; Sebastiani T; Panunzi S; Valente D
    J Sleep Res; 2012 Dec; 21(6):700-9. PubMed ID: 22616853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-help treatment for insomnia symptoms associated with chronic conditions in older adults: a randomized controlled trial.
    Morgan K; Gregory P; Tomeny M; David BM; Gascoigne C
    J Am Geriatr Soc; 2012 Oct; 60(10):1803-10. PubMed ID: 23035962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Controlled Pilot Trial of Behavioral Insomnia Treatment for Chronic Migraine With Comorbid Insomnia.
    Smitherman TA; Walters AB; Davis RE; Ambrose CE; Roland M; Houle TT; Rains JC
    Headache; 2016 Feb; 56(2):276-91. PubMed ID: 26813845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internight sleep variability: its clinical significance and responsiveness to treatment in primary and comorbid insomnia.
    Sánchez-Ortuño MM; Edinger JD
    J Sleep Res; 2012 Oct; 21(5):527-34. PubMed ID: 22463493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomnia.
    Hajak G; Rodenbeck A; Adler L; Huether G; Bandelow B; Herrendorf G; Staedt J; Rüther E
    Pharmacopsychiatry; 1996 Sep; 29(5):187-92. PubMed ID: 8895944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks.
    Rodenbeck A; Cohrs S; Jordan W; Huether G; Rüther E; Hajak G
    Psychopharmacology (Berl); 2003 Dec; 170(4):423-8. PubMed ID: 13680082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
    Fernandez HH; Okun MS; Rodriguez RL; Malaty IA; Romrell J; Sun A; Wu SS; Pillarisetty S; Nyathappa A; Eisenschenk S
    Int J Neurosci; 2009; 119(12):2196-205. PubMed ID: 19916848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I-CAN SLEEP: rationale and design of a non-inferiority RCT of Mindfulness-based Stress Reduction and Cognitive Behavioral Therapy for the treatment of Insomnia in CANcer survivors.
    Garland SN; Carlson LE; Antle MC; Samuels C; Campbell T
    Contemp Clin Trials; 2011 Sep; 32(5):747-54. PubMed ID: 21658476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia.
    Roth T; Rogowski R; Hull S; Schwartz H; Koshorek G; Corser B; Seiden D; Lankford A
    Sleep; 2007 Nov; 30(11):1555-61. PubMed ID: 18041488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study.
    De Cock VC; Dodet P; Leu-Semenescu S; Aerts C; Castelnovo G; Abril B; Drapier S; Olivet H; Corbillé AG; Leclair-Visonneau L; Sallansonnet-Froment M; Lebouteux M; Anheim M; Ruppert E; Vitello N; Eusebio A; Lambert I; Marques A; Fantini ML; Devos D; Monaca C; Benard-Serre N; Lacombe S; Vidailhet M; Arnulf I; Doulazmi M; Roze E
    Lancet Neurol; 2022 May; 21(5):428-437. PubMed ID: 35429481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive-behavioral therapy for sleep disturbance in patients undergoing peritoneal dialysis: a pilot randomized controlled trial.
    Chen HY; Chiang CK; Wang HH; Hung KY; Lee YJ; Peng YS; Wu KD; Tsai TJ
    Am J Kidney Dis; 2008 Aug; 52(2):314-23. PubMed ID: 18511165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.